C. Piketty, P. Castiel, L. Belec, D. Batisse, S. Mohamed et al., Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease, AIDS, vol.12, issue.7, pp.745-750, 1998.
DOI : 10.1097/00002030-199807000-00011

M. Ragni, C. Moore, K. Soadwa, M. Nalesnik, A. Zajko et al., Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia, Haemophilia, vol.49, issue.Suppl, pp.103-111, 2011.
DOI : 10.1111/j.1365-2516.2010.02366.x

M. Koziel and M. Peters, Viral Hepatitis in HIV Infection, New England Journal of Medicine, vol.356, issue.14, pp.1445-1454, 2007.
DOI : 10.1056/NEJMra065142

A. Monforte, D. Abrams, C. Pradier, R. Weber, P. Reiss et al., HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies, AIDS, vol.22, pp.2143-2153, 2008.

B. Krämer, C. Körner, M. Kebschull, A. Glässner, M. Eisenhardt et al., (High) expression defines a NK cell subset that is potentially involved in control of HCV replication and modulation of liver fibrosis, Hepatology, vol.2012, issue.564, pp.461201-1213

G. Alter, J. Malenfant, R. Delabre, N. Burgett, X. Yu et al., Increased Natural Killer Cell Activity in Viremic HIV-1 Infection, The Journal of Immunology, vol.173, issue.8, pp.5305-5311, 2004.
DOI : 10.4049/jimmunol.173.8.5305

G. Alter, J. Malenfant, and M. Altfeld, CD107a as a functional marker for the identification of natural killer cell activity, Journal of Immunological Methods, vol.294, issue.1-2, pp.15-22, 2004.
DOI : 10.1016/j.jim.2004.08.008

E. Aktas, U. Kucuksezer, S. Bilgic, G. Erten, and G. Deniz, Relationship between CD107a expression and cytotoxic activity, Cellular Immunology, vol.254, issue.2, pp.149-154, 2009.
DOI : 10.1016/j.cellimm.2008.08.007

A. Nagler, L. Lanier, S. Cwirla, and J. Phillips, Comparative studies of human FcRIIIpositive and negative natural killer cells, J Immunol, vol.143, pp.3183-3191, 1989.

G. Alter, N. Teigen, B. Davis, M. Addo, T. Suscovich et al., Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection, Blood, vol.106, issue.10, pp.3366-3369, 2005.
DOI : 10.1182/blood-2005-03-1100

V. Gonzalez, K. Falconer, J. Michaelsson, M. Moll, O. Reichard et al., Expansion of CD56??? NK cells in chronic HCV/HIV-1 co-infection: Reversion by antiviral treatment with pegylated IFN?? and ribavirin, Clinical Immunology, vol.128, issue.1, pp.46-56, 2008.
DOI : 10.1016/j.clim.2008.03.521

H. Hong, J. Eberhard, P. Keudel, B. Bollmann, F. Ahmad et al., Phenotypically and functionally distinct subsets contribute to the expansion of CD56???/CD16+ natural killer cells in HIV infection, AIDS, vol.24, issue.12, pp.1823-1834, 2010.
DOI : 10.1097/QAD.0b013e32833b556f

U. Meier, R. Owen, E. Taylor, A. Worth, N. Naoumov et al., Shared Alterations in NK Cell Frequency, Phenotype, and Function in Chronic Human Immunodeficiency Virus and Hepatitis C Virus Infections, Journal of Virology, vol.79, issue.19
DOI : 10.1128/JVI.79.19.12365-12374.2005

P. Mantegani, G. Tambussi, L. Galli, C. Din, A. Lazzarin et al., subset, Immunology, vol.197, issue.2, pp.220-233, 2010.
DOI : 10.1111/j.1365-2567.2009.03171.x

M. Fogli, P. Costa, G. Murdaca, M. Setti, M. Mingari et al., Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients, European Journal of Immunology, vol.34, issue.8, pp.2313-2321, 2004.
DOI : 10.1002/eji.200425251

G. Ironson, E. Balbin, G. Solomon, J. Fahey, N. Klimas et al., Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts, AIDS, vol.15, issue.16, pp.2065-2073, 2001.
DOI : 10.1097/00002030-200111090-00001

M. Cooper, T. Fehniger, and M. Caligiuri, The biology of human natural killer-cell subsets, Trends in Immunology, vol.22, issue.11, pp.633-640, 2001.
DOI : 10.1016/S1471-4906(01)02060-9

J. Parrish-novak, S. Dillon, A. Nelson, A. Hammond, C. Sprecher et al., Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function, Nature, vol.408, pp.57-63, 2000.

V. Vieillard, J. Strominger, and P. Debre, NK cytotoxicity against CD4+ T cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand, Proceedings of the National Academy of Sciences, vol.102, issue.31, pp.10981-10986, 2005.
DOI : 10.1073/pnas.0504315102

A. Freud, B. Becknell, S. Roychowdhury, H. Mao, A. Ferketich et al., A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer Cells, Immunity, vol.22, issue.3, pp.295-304, 2005.
DOI : 10.1016/j.immuni.2005.01.013

B. Smith, S. Gartner, Y. Liu, A. Perelson, N. Stilianakis et al., Persistence of Infectious HIV on Follicular Dendritic Cells, The Journal of Immunology, vol.166, issue.1, pp.690-696, 2001.
DOI : 10.4049/jimmunol.166.1.690

R. Zhang, J. Xu, K. Hong, L. Yuan, H. Peng et al., Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status, AIDS, vol.21, issue.Suppl 8, pp.9-17, 2007.
DOI : 10.1097/01.aids.0000304691.32014.19

D. Mavilio, J. Benjamin, M. Daucher, G. Lombardo, S. Kottilil et al., Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates, Proceedings of the National Academy of Sciences, vol.100, issue.25, pp.15011-15016, 2003.
DOI : 10.1073/pnas.2336091100

D. Mavilio, G. Lombardo, J. Benjamin, D. Kim, D. Follman et al., Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals, Proceedings of the National Academy of Sciences, vol.102, issue.8, pp.2886-2891, 2005.
DOI : 10.1073/pnas.0409872102

A. Tagliaferri, D. Perna, C. Santoro, C. Schinco, P. Santoro et al., Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers, Journal of Thrombosis and Haemostasis, vol.96, issue.Suppl. 5, pp.90-95, 2012.
DOI : 10.1111/j.1538-7836.2011.04566.x

I. Bica, B. Mcgovern, R. Dhar, D. Stone, K. Mcgowan et al., Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection, Clinical Infectious Diseases, vol.32, issue.3, pp.492-497, 2001.
DOI : 10.1086/318501

G. Greub, B. Ledergerber, M. Battegay, P. Grob, L. Perrin et al., Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study, The Lancet, vol.356, issue.9244, pp.1800-1805, 2000.
DOI : 10.1016/S0140-6736(00)03232-3

L. Piroth, M. Duong, C. Quantin, M. Abrahamowicz, R. Michardiere et al., Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS, pp.381-388, 1998.

E. Daar, H. Lynn, S. Donfield, E. Gomperts, O. Brien et al., Hepatitis C Virus Load Is Associated with Human Immunodeficiency Virus Type 1 Disease Progression in Hemophiliacs, The Journal of Infectious Diseases, vol.183, issue.4, pp.589-595, 2001.
DOI : 10.1086/318539

L. Piroth, M. Grappin, L. Cuzin, Y. Mouton, O. Bouchard et al., Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients, Journal of Viral Hepatitis, vol.92, issue.4, pp.302-308, 2000.
DOI : 10.1016/S0140-6736(96)07642-8

P. Braitstein, A. Palepu, D. Dieterich, Y. Benhamou, and J. Montaner, Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C, AIDS, vol.18, issue.17, pp.2221-2234, 2004.
DOI : 10.1097/00002030-200411190-00002

N. Gupta, J. Arthos, P. Khazanie, T. Steenbeke, N. Censoplano et al., Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy, Virology, vol.332, issue.2, pp.491-497, 2005.
DOI : 10.1016/j.virol.2004.12.018

. Fregni, High number of CD56bright NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections, Virology Journal, vol.10, issue.1, p.33, 2013.
DOI : 10.1016/j.virol.2004.12.018
URL : https://hal.archives-ouvertes.fr/inserm-00786505